3.44 USD
↘ 0.32 (8.51%)AT CLOSE (11:59 AM EDT)
CervoMed Inc. Common Stock
CRVONASDAQ • USD
3.40
↘ 0.05 (1.31%)
POST MARKET (AS OF 07:46 PM EDT)
Post Market
AS OF 07:46 PM EDT
3.40
↘ 0.05 (1.31%)
Market: CLOSED
Open?$3.74
High?$3.74
Low?$3.35
Prev. Close?$3.76
Volume?119.6K
Avg. Volume?41.7K
VWAP?$3.54
Rel. Volume?2.87x
Bid / Ask
Bid?$2.88 × 100
Ask?$3.92 × 100
Spread?$1.04
Midpoint?$3.40
Valuation & Ratios
Market Cap?31.8M
Shares Out?9.3M
Float?5.9M
Float %?63.7%
P/E Ratio?N/A
P/B Ratio?1.75
EPS?-$2.91
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod, has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.
Employees
15
Market Cap
31.8M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
1996-06-18
Address
20 PARK PLAZA
BOSTON, MA 02116
Phone: (617) 744-4400
BOSTON, MA 02116
Phone: (617) 744-4400
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?4.91Strong
Quick Ratio?4.91Strong
Cash Ratio?1.77Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUED
Score75/100
P/E?N/A▾
P/B?1.75CHEAP▾
P/S?7.95HIGH▾
P/FCF?N/A▾
EV/EBITDA?-0.8CHEAP▾
EV/Sales?5.89FAIR▾
Returns & Efficiency
ROE?-148.0%WEAK▾
ROA?-117.9%WEAK▾
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$23.6M
Fundamentals ratios updated end of day